Biotech Acquisition Statistics Share Statistics Biotech Acquisition has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 246 FTD / Avg. Volume 0.24%
Short Selling Information The latest short interest is 977, so 0% of the outstanding
shares have been sold short.
Short Interest 977 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -23.27 and the forward
PE ratio is null.
Biotech Acquisition's PEG ratio is
0.
PE Ratio -23.27 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -10412315.55 P/FCF Ratio -193.08 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biotech Acquisition.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.95,
with a Debt / Equity ratio of 0.
Current Ratio 0.95 Quick Ratio 0.95 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -0.3
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 5.29M Effective Tax Rate -77.12%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Biotech Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.09 200-Day Moving Average 9.91 Relative Strength Index (RSI) 48.69 Average Volume (20 Days) 103,991
Income Statement
Revenue n/a Gross Profit -1.57M Operating Income -1.57M Net Income -12.16M EBITDA -6.87M EBIT -1.57M Earnings Per Share (EPS) -0.42
Full Income Statement Balance Sheet The company has 0.09 in cash and 0 in
debt, giving a net cash position of 0.09.
Cash & Cash Equivalents 0.09 Total Debt n/a Net Cash n/a Retained Earnings -27.17 Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.47M
and capital expenditures 0, giving a free cash flow of -1.47M.
Operating Cash Flow -1.47M Capital Expenditures n/a Free Cash Flow -1.47M FCF Per Share -0.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
